{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:08:12Z","timestamp":1772172492130,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007223","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000}}],"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007223","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T13:36:50Z","timestamp":1565617010000},"page":"e1007223","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Aggressive or moderate drug therapy for infectious diseases? Trade-offs between different treatment goals at the individual and population levels"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0059-645X","authenticated-orcid":true,"given":"J\u00e9r\u00e9mie","family":"Scire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-8966","authenticated-orcid":true,"given":"Nathana\u00ebl","family":"Hoz\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-2813","authenticated-orcid":true,"given":"Hildegard","family":"Uecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"issue":"1","key":"pcbi.1007223.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"HW Boucher","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"pcbi.1007223.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkr378","article-title":"The emergence of pan-resistant gram-negative pathogens merits a rapid global political response","volume":"67","author":"TR Walsh","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"pcbi.1007223.ref003","unstructured":"Centres for Disease Control and Prevention (US). Antibiotic resistance threats in the United States, 2013. Centres for Disease Control and Prevention, US Department of Health and Human Services; 2013."},{"key":"pcbi.1007223.ref004","article-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"J O\u2019Neill","year":"2016","journal-title":"Review on Antimicrobial Resistance"},{"issue":"1794","key":"pcbi.1007223.ref005","doi-asserted-by":"crossref","first-page":"20140566","DOI":"10.1098\/rspb.2014.0566","article-title":"The path of least resistance: aggressive or moderate treatment?","volume":"281","author":"RD Kouyos","year":"2014","journal-title":"Proceedings of the Royal Society B: Biological Sciences"},{"issue":"2746","key":"pcbi.1007223.ref006","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.2.2746.353","article-title":"Address in Pathology, ON CHEMIOTHERAPY: Delivered before the Seventeenth International Congress of Medicine","volume":"2","author":"P Ehrlich","year":"1913","journal-title":"British Medical Journal"},{"key":"pcbi.1007223.ref007","volume-title":"Nobel Lecture","author":"A Fleming","year":"1945"},{"issue":"1","key":"pcbi.1007223.ref008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"K Drlica","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"6","key":"pcbi.1007223.ref009","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.pcbi.1000796","article-title":"Optimal drug synergy in antimicrobial treatments","volume":"6","author":"JP Torella","year":"2010","journal-title":"PLoS Computational Biology"},{"key":"pcbi.1007223.ref010","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1073\/pnas.1100299108","article-title":"The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy","volume":"108","author":"AF Read","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"pcbi.1007223.ref011","doi-asserted-by":"crossref","first-page":"e1001540","DOI":"10.1371\/journal.pbio.1001540","article-title":"When the Most Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile-Frown Transition","volume":"11","author":"R Pena-Miller","year":"2013","journal-title":"PLoS Biology"},{"issue":"1","key":"pcbi.1007223.ref012","article-title":"Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?","volume":"12","author":"T Day","year":"2016","journal-title":"PLoS Computational Biology"},{"issue":"11","key":"pcbi.1007223.ref013","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tim.2017.07.005","article-title":"Phagocytes, Antibiotics, and Self-Limiting Bacterial Infections","volume":"25","author":"BR Levin","year":"2017","journal-title":"Trends in Microbiology"},{"issue":"9","key":"pcbi.1007223.ref014","doi-asserted-by":"crossref","first-page":"e1003578","DOI":"10.1371\/journal.ppat.1003578","article-title":"Aggressive chemotherapy and the selection of drug resistant pathogens","volume":"9","author":"S Huijben","year":"2013","journal-title":"PLoS Pathogens"},{"issue":"50","key":"pcbi.1007223.ref015","doi-asserted-by":"crossref","first-page":"19914","DOI":"10.1073\/pnas.0707766104","article-title":"Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model","volume":"104","author":"AR Wargo","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"pcbi.1007223.ref016","doi-asserted-by":"crossref","first-page":"e1004019","DOI":"10.1371\/journal.ppat.1004019","article-title":"Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites","volume":"10","author":"LC Pollitt","year":"2014","journal-title":"PLoS Pathogens"},{"issue":"10","key":"pcbi.1007223.ref017","first-page":"2952","article-title":"CHEMOTHERAPY, WITHIN-HOST ECOLOGY AND THE FITNESS OF DRUG-RESISTANT MALARIA PARASITES","volume":"64","author":"S Huijben","year":"2010","journal-title":"Evolution"},{"issue":"2","key":"pcbi.1007223.ref018","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/AAC.00334-06","article-title":"The relationship between quinolone exposure and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance","volume":"51","author":"VH Tam","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"pcbi.1007223.ref019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkh242","article-title":"ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model","volume":"54","author":"AA Firsov","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"pcbi.1007223.ref020","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/AAC.47.5.1604-1613.2003","article-title":"In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus","volume":"47","author":"AA Firsov","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"pcbi.1007223.ref021","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dkl387","article-title":"Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model","volume":"58","author":"AA Firsov","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"pcbi.1007223.ref022","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkg401","article-title":"Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing","volume":"52","author":"SH Zinner","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"pcbi.1007223.ref023","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1128\/AAC.48.5.1699-1707.2004","article-title":"Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy","volume":"48","author":"D Croisier","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"pcbi.1007223.ref024","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1128\/AAC.01486-06","article-title":"Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection","volume":"51","author":"LE Stearne","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"pcbi.1007223.ref025","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","author":"AM Schmalstieg","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"pcbi.1007223.ref026","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/AAC.44.9.2485-2491.2000","article-title":"Concentration-dependent selection of small phenotypic differences in TEM \u03b2-lactamase-mediated antibiotic resistance","volume":"44","author":"MC Negri","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pcbi.1007223.ref027","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/459508a","article-title":"A change of strategy in the war on cancer","volume":"459","author":"RA Gatenby","year":"2009","journal-title":"Nature"},{"issue":"23","key":"pcbi.1007223.ref028","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1073\/pnas.1400352111","article-title":"Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections","volume":"111","author":"P Ankomah","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"pcbi.1007223.ref029","doi-asserted-by":"crossref","first-page":"e1004857","DOI":"10.1371\/journal.pcbi.1004857","article-title":"Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment","volume":"12","author":"E Gjini","year":"2016","journal-title":"PLoS Computational Biology"},{"issue":"September2015","key":"pcbi.1007223.ref030","first-page":"1","article-title":"How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance","volume":"4","author":"C Colijn","year":"2015","journal-title":"eLife"},{"issue":"6","key":"pcbi.1007223.ref031","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tim.2017.11.005","article-title":"The Search for\u2019Evolution-Proof\u2019 Antibiotics","volume":"26","author":"G Bell","year":"2018","journal-title":"Trends in Microbiology"},{"issue":"12","key":"pcbi.1007223.ref032","doi-asserted-by":"crossref","first-page":"e2003533","DOI":"10.1371\/journal.pbio.2003533","article-title":"Alternative therapeutics for self-limiting infections\u2014An indirect approach to the antibiotic resistance challenge","volume":"15","author":"KW Waldetoft","year":"2017","journal-title":"PLoS biology"},{"issue":"25","key":"pcbi.1007223.ref033","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/j100540a008","article-title":"Exact Stochastic Simulation of Coupled Chemical Reactions","volume":"81","author":"DT Gillespie","year":"1977","journal-title":"The Journal of Physical Chemistry"},{"issue":"4","key":"pcbi.1007223.ref034","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1063\/1.1378322","article-title":"Approximate accelerated stochastic simulation of chemically reacting systems","volume":"115","author":"DT Gillespie","year":"2001","journal-title":"The Journal of Chemical Physics"},{"key":"pcbi.1007223.ref035","volume-title":"Mathematical Epidemiology","author":"LJS Allen","year":"2008"},{"issue":"12","key":"pcbi.1007223.ref036","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.tim.2018.09.002","article-title":"Effectively evolution-proof antibiotics?","volume":"26","author":"H Uecker","year":"2018","journal-title":"Trends in microbiology"},{"issue":"1","key":"pcbi.1007223.ref037","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1371\/journal.pmed.0040015","article-title":"Antiviral resistance and the control of pandemic influenza","volume":"4","author":"M Lipsitch","year":"2007","journal-title":"PLoS Medicine"},{"key":"pcbi.1007223.ref038","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtbi.2008.09.021","article-title":"Antiviral resistance and the control of pandemic influenza: The roles of stochasticity, evolution and model details","volume":"256","author":"A Handel","year":"2009","journal-title":"Journal of Theoretical Biology"},{"key":"pcbi.1007223.ref039","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1098\/rspb.2008.0016","article-title":"Management of drug resistance in the population: influenza as a case study","volume":"275","author":"SM Moghadas","year":"2008","journal-title":"Proceedings of the Royal Society B"},{"issue":"3","key":"pcbi.1007223.ref040","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1371\/journal.pone.0001839","article-title":"Population-wide emergence of antiviral resistance during pandemic influenza","volume":"3","author":"SM Moghadas","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"pcbi.1007223.ref041","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tmaid.2016.11.010","article-title":"Antibiotic resistance and international travel: Causes and consequences","volume":"14","author":"E Kuenzli","year":"2016","journal-title":"Travel Medicine and Infectious Disease"},{"key":"pcbi.1007223.ref042","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/emph\/eou027","article-title":"Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics","author":"MM Tanaka","year":"2014","journal-title":"Evolution, Medicine, and Public Health"},{"key":"pcbi.1007223.ref043","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1098\/rspb.2010.1469","article-title":"Optimal antiviral treatment strategies and the effects of resistance","volume":"278","author":"E Hansen","year":"2011","journal-title":"Proceedings of the Royal Society B"},{"issue":"2","key":"pcbi.1007223.ref044","doi-asserted-by":"crossref","first-page":"e2001110","DOI":"10.1371\/journal.pbio.2001110","article-title":"How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient","volume":"15","author":"E Hansen","year":"2017","journal-title":"PLoS Biology"},{"key":"pcbi.1007223.ref045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.1122947","article-title":"Emergence of drug-resistant influenza virus: Population dynamical considerations","volume":"312","author":"RR Regoes","year":"2006","journal-title":"Science"},{"key":"pcbi.1007223.ref046","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1098\/rspb.2006.0015","article-title":"What is the best control strategy for multiple infectious disease outbreaks?","volume":"274","author":"A Handel","year":"2007","journal-title":"Proceedings of the Royal Society B"},{"issue":"1","key":"pcbi.1007223.ref047","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1038\/s41598-018-24006-w","article-title":"Beyond dose: Pulsed antibiotic treatment schedules can maintain individual benefit while reducing resistance","volume":"8","author":"CM Baker","year":"2018","journal-title":"Scientific reports"},{"issue":"20","key":"pcbi.1007223.ref048","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.95.20.11514","article-title":"Drug concentration heterogeneity facilitates the evolution of drug resistance","volume":"95","author":"TB Kepler","year":"1998","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"pcbi.1007223.ref049","first-page":"187","article-title":"Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance","volume":"2","author":"M Lipsitch","year":"1998","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"22","key":"pcbi.1007223.ref050","doi-asserted-by":"crossref","first-page":"E2874","DOI":"10.1073\/pnas.1424184112","article-title":"Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance","volume":"112","author":"S Moreno-Gamez","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1007223.ref051","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/30918","article-title":"Collective dynamics of \u2018small-world\u2019 networks","volume":"393","author":"DJ Watts","year":"1998","journal-title":"Nature"},{"key":"pcbi.1007223.ref052","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature04153","article-title":"Superspreading and the effect of individual variation on disease emergence","volume":"438","author":"J Lloyd-Smith","year":"2005","journal-title":"Nature"},{"issue":"6101","key":"pcbi.1007223.ref053","article-title":"Evolution and emergence of infectious diseases in theoretical and real-world networks","volume":"6","author":"GE Leventhal","year":"2015","journal-title":"Nature Communications"},{"issue":"3","key":"pcbi.1007223.ref054","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1128\/AAC.02135-13","article-title":"Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora","volume":"58","author":"MV Vasseur","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"pcbi.1007223.ref055","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1128\/AAC.06402-11","article-title":"Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?","volume":"56","author":"TT Nguyen","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"pcbi.1007223.ref056","doi-asserted-by":"crossref","first-page":"e1003840","DOI":"10.1371\/journal.pcbi.1003840","article-title":"Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted","volume":"10","author":"TT Nguyen","year":"2014","journal-title":"PLoS Computational Biology"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007223","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:25:48Z","timestamp":1589023548000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007223"}},"subtitle":[],"editor":[{"given":"Ted","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007223","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/307223","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]}}}